Shares of Sleep Number Corporation (NASDAQ: SNBR) rallied on Tuesday, jumping 60% to close at $3.55 after the company announced a critical financing agreement that injects $55 million in liquidity and relaxes some credit agreement tests. The stock hit an intraday high of $4.20 before pulling back, with trading volume surging past 38 million shares, reflecting heightened investor interest in the struggling mattress maker's turnaround prospects.
Details of the Lender Agreement
The deal includes a new $25 million term loan that matures on June 30, 2026, carrying an interest rate of one-month SOFR plus 8%. Additionally, lenders have agreed to forbear on enforcing certain defaults related to leverage, interest coverage, and adjusted EBITDA until July 1, 2026, unless a termination event occurs earlier. The company's $30 million minimum liquidity covenant will not be enforced until the last business day of the first week ending after July 1. A $5 million principal payment is due on June 1.
This financing comes just weeks after Sleep Number issued a going-concern warning in early March, expressing substantial doubt about its ability to continue as a going concern. The new liquidity provides a temporary reprieve, allowing the company to focus on product revamps and marketing initiatives ahead of the critical Memorial Day sales period.
Strategic Initiatives and Product Overhaul
Sleep Number is using the breathing room to accelerate its turnaround strategy. The company recently slashed its mattress lineup from 12 models to seven, its biggest product overhaul in nearly a decade, emphasizing adjustability and temperature control features. It also launched its first major integrated marketing campaign in years, highlighting the updated lineup.
Chief Marketing Officer Amber Minson noted that since sleep varies nightly, the mattress should adapt accordingly. President and CEO Linda Findley pointed to positive customer reviews and an improved Net Promoter Score as early indicators of traction. The company is also targeting cost savings, having achieved $185 million in annualized reductions and aiming for another $50 million in 2026.
Financial Performance and Market Context
Sleep Number reported 2025 net sales of $1.4 billion, a 16% decline from the prior year, and a net loss of $132 million. The company's market capitalization stands at roughly $81.5 million following the stock surge. First-quarter results are scheduled for release on May 12, 2026, with investors closely watching for signs that the financing bridge and new products are translating into sales growth.
The mattress industry remains fiercely competitive, with Sleep Number facing rivals like Tempur-Pedic, Sealy, Serta, and online-first brands such as Purple, Casper, and Saatva. Many competitors have greater financial resources and broader distribution networks, making the company's turnaround efforts particularly challenging.
Outlook and Risks
While the lender agreement provides critical short-term liquidity, it is not a permanent solution. The forbearance period can be revoked by lenders at any time, and once it ends or if another default trigger occurs, they can reinstate remedies such as acceleration rights. CFO Amy O'Keefe acknowledged ongoing work on a longer-term capital structure solution. The company's ability to return to profitability and generate sustainable cash flow will be key to restoring investor confidence and avoiding further distress.
